nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0311	0.0433	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0311	0.0433	CbGbCtD
Nefazodone—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0269	0.0374	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0269	0.0374	CbGbCtD
Nefazodone—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0261	0.0363	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0261	0.0363	CbGbCtD
Nefazodone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0258	0.0359	CbGbCtD
Nefazodone—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0236	0.0328	CbGbCtD
Nefazodone—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0236	0.0328	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0236	0.0328	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0236	0.0328	CbGbCtD
Nefazodone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0233	0.0325	CbGbCtD
Nefazodone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0233	0.0325	CbGbCtD
Nefazodone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0201	0.028	CbGbCtD
Nefazodone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0196	0.0272	CbGbCtD
Nefazodone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0177	0.0246	CbGbCtD
Nefazodone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0177	0.0246	CbGbCtD
Nefazodone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0168	0.0234	CbGbCtD
Nefazodone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0168	0.0234	CbGbCtD
Nefazodone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0158	0.022	CbGbCtD
Nefazodone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0158	0.022	CbGbCtD
Nefazodone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0152	0.0211	CbGbCtD
Nefazodone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0143	0.0199	CbGbCtD
Nefazodone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0143	0.0199	CbGbCtD
Nefazodone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0131	0.0182	CbGbCtD
Nefazodone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0127	0.0177	CbGbCtD
Nefazodone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0124	0.0172	CbGbCtD
Nefazodone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.012	0.0167	CbGbCtD
Nefazodone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0115	0.016	CbGbCtD
Nefazodone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0115	0.016	CbGbCtD
Nefazodone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.011	0.0154	CbGbCtD
Nefazodone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0108	0.0151	CbGbCtD
Nefazodone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0108	0.0151	CbGbCtD
Nefazodone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0107	0.0149	CbGbCtD
Nefazodone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0101	0.014	CbGbCtD
Nefazodone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0101	0.014	CbGbCtD
Nefazodone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0091	0.0127	CbGbCtD
Nefazodone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0091	0.0127	CbGbCtD
Nefazodone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00854	0.0119	CbGbCtD
Nefazodone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00786	0.0109	CbGbCtD
Nefazodone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00763	0.0106	CbGbCtD
Nefazodone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0069	0.0096	CbGbCtD
Nefazodone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0069	0.0096	CbGbCtD
Nefazodone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00661	0.0092	CbGbCtD
Nefazodone—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00217	0.0564	CbGeAlD
Nefazodone—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00175	0.0455	CbGeAlD
Nefazodone—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.00151	0.0391	CbGeAlD
Nefazodone—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00134	0.0347	CbGeAlD
Nefazodone—HTR2A—nerve—acquired immunodeficiency syndrome	0.00105	0.0273	CbGeAlD
Nefazodone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000983	0.0255	CbGeAlD
Nefazodone—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000937	0.0243	CbGeAlD
Nefazodone—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000897	0.0233	CbGeAlD
Nefazodone—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000797	0.0207	CbGeAlD
Nefazodone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000738	0.0191	CbGeAlD
Nefazodone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000726	0.0188	CbGeAlD
Nefazodone—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000653	0.0169	CbGeAlD
Nefazodone—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000628	0.0163	CbGeAlD
Nefazodone—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.00058	0.0151	CbGeAlD
Nefazodone—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.000579	0.015	CbGeAlD
Nefazodone—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000561	0.0146	CbGeAlD
Nefazodone—SLC6A4—blood—acquired immunodeficiency syndrome	0.000552	0.0143	CbGeAlD
Nefazodone—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.000532	0.0138	CbGeAlD
Nefazodone—SLC6A3—lung—acquired immunodeficiency syndrome	0.000528	0.0137	CbGeAlD
Nefazodone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000522	0.0136	CbGeAlD
Nefazodone—ADRA1B—brain—acquired immunodeficiency syndrome	0.000499	0.0129	CbGeAlD
Nefazodone—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000489	0.0127	CbGeAlD
Nefazodone—SLC6A4—lung—acquired immunodeficiency syndrome	0.000484	0.0126	CbGeAlD
Nefazodone—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00048	0.0125	CbGeAlD
Nefazodone—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000472	0.0123	CbGeAlD
Nefazodone—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000472	0.0122	CbGeAlD
Nefazodone—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000471	0.0122	CbGeAlD
Nefazodone—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000455	0.0118	CbGeAlD
Nefazodone—ADRA1A—blood—acquired immunodeficiency syndrome	0.000452	0.0117	CbGeAlD
Nefazodone—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.000448	0.0116	CbGeAlD
Nefazodone—HTR2A—retina—acquired immunodeficiency syndrome	0.000436	0.0113	CbGeAlD
Nefazodone—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.000431	0.0112	CbGeAlD
Nefazodone—SLC6A2—lung—acquired immunodeficiency syndrome	0.000426	0.0111	CbGeAlD
Nefazodone—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000398	0.0103	CbGeAlD
Nefazodone—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000394	0.0102	CbGeAlD
Nefazodone—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000383	0.00994	CbGeAlD
Nefazodone—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00038	0.00985	CbGeAlD
Nefazodone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000378	0.00981	CbGeAlD
Nefazodone—SLC6A3—brain—acquired immunodeficiency syndrome	0.000374	0.0097	CbGeAlD
Nefazodone—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000367	0.00951	CbGeAlD
Nefazodone—HTR2C—brain—acquired immunodeficiency syndrome	0.000361	0.00937	CbGeAlD
Nefazodone—CYP3A5—blood—acquired immunodeficiency syndrome	0.00036	0.00935	CbGeAlD
Nefazodone—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000353	0.00916	CbGeAlD
Nefazodone—ADRA2A—blood—acquired immunodeficiency syndrome	0.000343	0.00891	CbGeAlD
Nefazodone—SLC6A4—brain—acquired immunodeficiency syndrome	0.000342	0.00888	CbGeAlD
Nefazodone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000334	0.00866	CbGeAlD
Nefazodone—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000331	0.00858	CbGeAlD
Nefazodone—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000318	0.00826	CbGeAlD
Nefazodone—CYP3A5—lung—acquired immunodeficiency syndrome	0.000316	0.00819	CbGeAlD
Nefazodone—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000306	0.00795	CbGeAlD
Nefazodone—HTR1A—brain—acquired immunodeficiency syndrome	0.000304	0.00789	CbGeAlD
Nefazodone—SLC6A2—brain—acquired immunodeficiency syndrome	0.000301	0.00782	CbGeAlD
Nefazodone—ADRA2A—lung—acquired immunodeficiency syndrome	0.000301	0.00781	CbGeAlD
Nefazodone—HTR2A—blood—acquired immunodeficiency syndrome	0.000292	0.00758	CbGeAlD
Nefazodone—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000291	0.00756	CbGeAlD
Nefazodone—ABCB1—retina—acquired immunodeficiency syndrome	0.000286	0.00742	CbGeAlD
Nefazodone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000284	0.00736	CbGeAlD
Nefazodone—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000281	0.0073	CbGeAlD
Nefazodone—ADRA1A—brain—acquired immunodeficiency syndrome	0.00028	0.00727	CbGeAlD
Nefazodone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000279	0.00724	CbGeAlD
Nefazodone—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000279	0.00723	CbGeAlD
Nefazodone—HTR2A—vagina—acquired immunodeficiency syndrome	0.000271	0.00702	CbGeAlD
Nefazodone—CYP3A4—blood—acquired immunodeficiency syndrome	0.00027	0.00701	CbGeAlD
Nefazodone—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000268	0.00696	CbGeAlD
Nefazodone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000266	0.0069	CbGeAlD
Nefazodone—HTR2A—lung—acquired immunodeficiency syndrome	0.000256	0.00664	CbGeAlD
Nefazodone—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000237	0.00615	CbGeAlD
Nefazodone—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000228	0.00592	CbGeAlD
Nefazodone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000219	0.00569	CbGeAlD
Nefazodone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000216	0.0056	CbGeAlD
Nefazodone—ADRA2A—brain—acquired immunodeficiency syndrome	0.000213	0.00553	CbGeAlD
Nefazodone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000211	0.00548	CbGeAlD
Nefazodone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000208	0.00539	CbGeAlD
Nefazodone—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000206	0.00534	CbGeAlD
Nefazodone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000203	0.00528	CbGeAlD
Nefazodone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000201	0.00521	CbGeAlD
Nefazodone—ABCB1—blood—acquired immunodeficiency syndrome	0.000191	0.00496	CbGeAlD
Nefazodone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000185	0.0048	CbGeAlD
Nefazodone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000184	0.00478	CbGeAlD
Nefazodone—HTR2A—brain—acquired immunodeficiency syndrome	0.000181	0.0047	CbGeAlD
Nefazodone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000177	0.0046	CbGeAlD
Nefazodone—ABCB1—lung—acquired immunodeficiency syndrome	0.000168	0.00435	CbGeAlD
Nefazodone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000165	0.00428	CbGeAlD
Nefazodone—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000155	0.00403	CbGeAlD
Nefazodone—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.00015	0.00388	CbGeAlD
Nefazodone—ABCB1—brain—acquired immunodeficiency syndrome	0.000119	0.00308	CbGeAlD
Nefazodone—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000484	CcSEcCtD
Nefazodone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000484	CcSEcCtD
Nefazodone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000484	CcSEcCtD
Nefazodone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000483	CcSEcCtD
Nefazodone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000483	CcSEcCtD
Nefazodone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000482	CcSEcCtD
Nefazodone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000482	CcSEcCtD
Nefazodone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.000481	CcSEcCtD
Nefazodone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000117	0.00048	CcSEcCtD
Nefazodone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000117	0.00048	CcSEcCtD
Nefazodone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000116	0.000479	CcSEcCtD
Nefazodone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000478	CcSEcCtD
Nefazodone—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000478	CcSEcCtD
Nefazodone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000477	CcSEcCtD
Nefazodone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000477	CcSEcCtD
Nefazodone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000477	CcSEcCtD
Nefazodone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000477	CcSEcCtD
Nefazodone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000476	CcSEcCtD
Nefazodone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000476	CcSEcCtD
Nefazodone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000475	CcSEcCtD
Nefazodone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000474	CcSEcCtD
Nefazodone—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000115	0.00298	CbGeAlD
Nefazodone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000115	0.000472	CcSEcCtD
Nefazodone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000471	CcSEcCtD
Nefazodone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000471	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000471	CcSEcCtD
Nefazodone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000471	CcSEcCtD
Nefazodone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.00047	CcSEcCtD
Nefazodone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000468	CcSEcCtD
Nefazodone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000114	0.000468	CcSEcCtD
Nefazodone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000468	CcSEcCtD
Nefazodone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000467	CcSEcCtD
Nefazodone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000467	CcSEcCtD
Nefazodone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000467	CcSEcCtD
Nefazodone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000466	CcSEcCtD
Nefazodone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000465	CcSEcCtD
Nefazodone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000113	0.000465	CcSEcCtD
Nefazodone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000113	0.000465	CcSEcCtD
Nefazodone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000464	CcSEcCtD
Nefazodone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000464	CcSEcCtD
Nefazodone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000113	0.000463	CcSEcCtD
Nefazodone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000113	0.000463	CcSEcCtD
Nefazodone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000462	CcSEcCtD
Nefazodone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000462	CcSEcCtD
Nefazodone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000461	CcSEcCtD
Nefazodone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000461	CcSEcCtD
Nefazodone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000461	CcSEcCtD
Nefazodone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000461	CcSEcCtD
Nefazodone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.00046	CcSEcCtD
Nefazodone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000459	CcSEcCtD
Nefazodone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000459	CcSEcCtD
Nefazodone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000459	CcSEcCtD
Nefazodone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000458	CcSEcCtD
Nefazodone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000457	CcSEcCtD
Nefazodone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000111	0.000456	CcSEcCtD
Nefazodone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000455	CcSEcCtD
Nefazodone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000454	CcSEcCtD
Nefazodone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000452	CcSEcCtD
Nefazodone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000451	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000451	CcSEcCtD
Nefazodone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.00045	CcSEcCtD
Nefazodone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000449	CcSEcCtD
Nefazodone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000449	CcSEcCtD
Nefazodone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000449	CcSEcCtD
Nefazodone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.000449	CcSEcCtD
Nefazodone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000448	CcSEcCtD
Nefazodone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000109	0.000448	CcSEcCtD
Nefazodone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000447	CcSEcCtD
Nefazodone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000447	CcSEcCtD
Nefazodone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000446	CcSEcCtD
Nefazodone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000446	CcSEcCtD
Nefazodone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000108	0.000446	CcSEcCtD
Nefazodone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000444	CcSEcCtD
Nefazodone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000444	CcSEcCtD
Nefazodone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000442	CcSEcCtD
Nefazodone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000442	CcSEcCtD
Nefazodone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000442	CcSEcCtD
Nefazodone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.000442	CcSEcCtD
Nefazodone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.000442	CcSEcCtD
Nefazodone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000441	CcSEcCtD
Nefazodone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000441	CcSEcCtD
Nefazodone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.00044	CcSEcCtD
Nefazodone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.00044	CcSEcCtD
Nefazodone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000107	0.000439	CcSEcCtD
Nefazodone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000438	CcSEcCtD
Nefazodone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000438	CcSEcCtD
Nefazodone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000438	CcSEcCtD
Nefazodone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000437	CcSEcCtD
Nefazodone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000437	CcSEcCtD
Nefazodone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000436	CcSEcCtD
Nefazodone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000435	CcSEcCtD
Nefazodone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000435	CcSEcCtD
Nefazodone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000433	CcSEcCtD
Nefazodone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000433	CcSEcCtD
Nefazodone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000433	CcSEcCtD
Nefazodone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000433	CcSEcCtD
Nefazodone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000432	CcSEcCtD
Nefazodone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000431	CcSEcCtD
Nefazodone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000105	0.00043	CcSEcCtD
Nefazodone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.00043	CcSEcCtD
Nefazodone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000428	CcSEcCtD
Nefazodone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.000428	CcSEcCtD
Nefazodone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000104	0.000428	CcSEcCtD
Nefazodone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000427	CcSEcCtD
Nefazodone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000104	0.000427	CcSEcCtD
Nefazodone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000104	0.000426	CcSEcCtD
Nefazodone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000426	CcSEcCtD
Nefazodone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000426	CcSEcCtD
Nefazodone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000425	CcSEcCtD
Nefazodone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000103	0.000424	CcSEcCtD
Nefazodone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000424	CcSEcCtD
Nefazodone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000423	CcSEcCtD
Nefazodone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000423	CcSEcCtD
Nefazodone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000423	CcSEcCtD
Nefazodone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000423	CcSEcCtD
Nefazodone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000422	CcSEcCtD
Nefazodone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000102	0.00042	CcSEcCtD
Nefazodone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000102	0.00042	CcSEcCtD
Nefazodone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00042	CcSEcCtD
Nefazodone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.00042	CcSEcCtD
Nefazodone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.00042	CcSEcCtD
Nefazodone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000418	CcSEcCtD
Nefazodone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000417	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000417	CcSEcCtD
Nefazodone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000101	0.000416	CcSEcCtD
Nefazodone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000416	CcSEcCtD
Nefazodone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000414	CcSEcCtD
Nefazodone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000413	CcSEcCtD
Nefazodone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.99e-05	0.000411	CcSEcCtD
Nefazodone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.99e-05	0.000411	CcSEcCtD
Nefazodone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.98e-05	0.000411	CcSEcCtD
Nefazodone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.98e-05	0.000411	CcSEcCtD
Nefazodone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	9.93e-05	0.000409	CcSEcCtD
Nefazodone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	9.93e-05	0.000409	CcSEcCtD
Nefazodone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	9.91e-05	0.000408	CcSEcCtD
Nefazodone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	9.9e-05	0.000408	CcSEcCtD
Nefazodone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	9.88e-05	0.000407	CcSEcCtD
Nefazodone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.86e-05	0.000406	CcSEcCtD
Nefazodone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.83e-05	0.000404	CcSEcCtD
Nefazodone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.8e-05	0.000403	CcSEcCtD
Nefazodone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	9.79e-05	0.000403	CcSEcCtD
Nefazodone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.78e-05	0.000403	CcSEcCtD
Nefazodone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.78e-05	0.000403	CcSEcCtD
Nefazodone—Nausea—Stavudine—acquired immunodeficiency syndrome	9.77e-05	0.000402	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.75e-05	0.000401	CcSEcCtD
Nefazodone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.73e-05	0.0004	CcSEcCtD
Nefazodone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000398	CcSEcCtD
Nefazodone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.66e-05	0.000398	CcSEcCtD
Nefazodone—Nausea—Abacavir—acquired immunodeficiency syndrome	9.62e-05	0.000396	CcSEcCtD
Nefazodone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.6e-05	0.000395	CcSEcCtD
Nefazodone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.55e-05	0.000393	CcSEcCtD
Nefazodone—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.54e-05	0.000393	CcSEcCtD
Nefazodone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.54e-05	0.000392	CcSEcCtD
Nefazodone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.000392	CcSEcCtD
Nefazodone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.51e-05	0.000391	CcSEcCtD
Nefazodone—Pain—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.000391	CcSEcCtD
Nefazodone—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.5e-05	0.000391	CcSEcCtD
Nefazodone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000391	CcSEcCtD
Nefazodone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.5e-05	0.000391	CcSEcCtD
Nefazodone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.45e-05	0.000389	CcSEcCtD
Nefazodone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.42e-05	0.000388	CcSEcCtD
Nefazodone—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.41e-05	0.000387	CcSEcCtD
Nefazodone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.3e-05	0.000383	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.3e-05	0.000383	CcSEcCtD
Nefazodone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.25e-05	0.000381	CcSEcCtD
Nefazodone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.00038	CcSEcCtD
Nefazodone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.16e-05	0.000377	CcSEcCtD
Nefazodone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.16e-05	0.000377	CcSEcCtD
Nefazodone—Pain—Saquinavir—acquired immunodeficiency syndrome	9.15e-05	0.000376	CcSEcCtD
Nefazodone—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.15e-05	0.000376	CcSEcCtD
Nefazodone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.1e-05	0.000374	CcSEcCtD
Nefazodone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.1e-05	0.000374	CcSEcCtD
Nefazodone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.09e-05	0.000374	CcSEcCtD
Nefazodone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.09e-05	0.000374	CcSEcCtD
Nefazodone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000373	CcSEcCtD
Nefazodone—Rash—Zidovudine—acquired immunodeficiency syndrome	9.01e-05	0.000371	CcSEcCtD
Nefazodone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.01e-05	0.000371	CcSEcCtD
Nefazodone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9e-05	0.000371	CcSEcCtD
Nefazodone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.98e-05	0.00037	CcSEcCtD
Nefazodone—Headache—Zidovudine—acquired immunodeficiency syndrome	8.95e-05	0.000369	CcSEcCtD
Nefazodone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.89e-05	0.000366	CcSEcCtD
Nefazodone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.87e-05	0.000365	CcSEcCtD
Nefazodone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	8.85e-05	0.000364	CcSEcCtD
Nefazodone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.83e-05	0.000363	CcSEcCtD
Nefazodone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.81e-05	0.000363	CcSEcCtD
Nefazodone—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.79e-05	0.000362	CcSEcCtD
Nefazodone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.79e-05	0.000362	CcSEcCtD
Nefazodone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.79e-05	0.000362	CcSEcCtD
Nefazodone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.75e-05	0.00036	CcSEcCtD
Nefazodone—Pain—Lamivudine—acquired immunodeficiency syndrome	8.73e-05	0.000359	CcSEcCtD
Nefazodone—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.73e-05	0.000359	CcSEcCtD
Nefazodone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.62e-05	0.000355	CcSEcCtD
Nefazodone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.59e-05	0.000354	CcSEcCtD
Nefazodone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.5e-05	0.00035	CcSEcCtD
Nefazodone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.5e-05	0.00035	CcSEcCtD
Nefazodone—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.49e-05	0.000349	CcSEcCtD
Nefazodone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.46e-05	0.000348	CcSEcCtD
Nefazodone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.46e-05	0.000348	CcSEcCtD
Nefazodone—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.45e-05	0.000348	CcSEcCtD
Nefazodone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.41e-05	0.000346	CcSEcCtD
Nefazodone—Rash—Indinavir—acquired immunodeficiency syndrome	8.38e-05	0.000345	CcSEcCtD
Nefazodone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.37e-05	0.000345	CcSEcCtD
Nefazodone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000343	CcSEcCtD
Nefazodone—Headache—Indinavir—acquired immunodeficiency syndrome	8.33e-05	0.000343	CcSEcCtD
Nefazodone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.31e-05	0.000342	CcSEcCtD
Nefazodone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.22e-05	0.000338	CcSEcCtD
Nefazodone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.19e-05	0.000337	CcSEcCtD
Nefazodone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.11e-05	0.000334	CcSEcCtD
Nefazodone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.07e-05	0.000332	CcSEcCtD
Nefazodone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.07e-05	0.000332	CcSEcCtD
Nefazodone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.99e-05	0.000329	CcSEcCtD
Nefazodone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.97e-05	0.000328	CcSEcCtD
Nefazodone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.95e-05	0.000327	CcSEcCtD
Nefazodone—Rash—Efavirenz—acquired immunodeficiency syndrome	7.92e-05	0.000326	CcSEcCtD
Nefazodone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.91e-05	0.000326	CcSEcCtD
Nefazodone—Nausea—Indinavir—acquired immunodeficiency syndrome	7.9e-05	0.000325	CcSEcCtD
Nefazodone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.88e-05	0.000324	CcSEcCtD
Nefazodone—Headache—Efavirenz—acquired immunodeficiency syndrome	7.87e-05	0.000324	CcSEcCtD
Nefazodone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.86e-05	0.000324	CcSEcCtD
Nefazodone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.67e-05	0.000316	CcSEcCtD
Nefazodone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.64e-05	0.000314	CcSEcCtD
Nefazodone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.6e-05	0.000313	CcSEcCtD
Nefazodone—Rash—Delavirdine—acquired immunodeficiency syndrome	7.58e-05	0.000312	CcSEcCtD
Nefazodone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.57e-05	0.000312	CcSEcCtD
Nefazodone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.57e-05	0.000311	CcSEcCtD
Nefazodone—Headache—Delavirdine—acquired immunodeficiency syndrome	7.53e-05	0.00031	CcSEcCtD
Nefazodone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.52e-05	0.000309	CcSEcCtD
Nefazodone—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.46e-05	0.000307	CcSEcCtD
Nefazodone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.35e-05	0.000302	CcSEcCtD
Nefazodone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.32e-05	0.000301	CcSEcCtD
Nefazodone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.32e-05	0.000301	CcSEcCtD
Nefazodone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.22e-05	0.000297	CcSEcCtD
Nefazodone—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.14e-05	0.000294	CcSEcCtD
Nefazodone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.07e-05	0.000291	CcSEcCtD
Nefazodone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.07e-05	0.000291	CcSEcCtD
Nefazodone—Rash—Ritonavir—acquired immunodeficiency syndrome	7.01e-05	0.000288	CcSEcCtD
Nefazodone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7e-05	0.000288	CcSEcCtD
Nefazodone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.98e-05	0.000287	CcSEcCtD
Nefazodone—Headache—Ritonavir—acquired immunodeficiency syndrome	6.96e-05	0.000287	CcSEcCtD
Nefazodone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.8e-05	0.00028	CcSEcCtD
Nefazodone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.75e-05	0.000278	CcSEcCtD
Nefazodone—Rash—Saquinavir—acquired immunodeficiency syndrome	6.74e-05	0.000278	CcSEcCtD
Nefazodone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.74e-05	0.000277	CcSEcCtD
Nefazodone—Headache—Saquinavir—acquired immunodeficiency syndrome	6.7e-05	0.000276	CcSEcCtD
Nefazodone—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.6e-05	0.000272	CcSEcCtD
Nefazodone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.49e-05	0.000267	CcSEcCtD
Nefazodone—Rash—Lamivudine—acquired immunodeficiency syndrome	6.43e-05	0.000265	CcSEcCtD
Nefazodone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.43e-05	0.000265	CcSEcCtD
Nefazodone—Headache—Lamivudine—acquired immunodeficiency syndrome	6.39e-05	0.000263	CcSEcCtD
Nefazodone—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.35e-05	0.000261	CcSEcCtD
Nefazodone—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.06e-05	0.000249	CcSEcCtD
